Donald Joseph
General Counsel bei ACER THERAPEUTICS INC.
Profil
Donald R.
Joseph is currently serving as the Secretary & Director at Bio Ventures for Global Health since 2010 and as the Secretary & Chief Legal Officer at Acer Therapeutics, Inc. since 2018.
Previously, he held positions such as Lead Independent Director at Achieve Life Sciences, Inc. from 2017 to 2023, Secretary, General Counsel & Senior Vice President at Abgenix, Inc., Secretary & General Counsel at Renovis, Inc., Secretary & Chief Legal Officer at Humanigen, Inc. in 2013, and Partner at Baker & McKenzie LLP (New York).
He also served as the Chief Operating Officer at PATH Drug Solutions.
Mr. Joseph obtained a graduate degree from The University of Texas School of Law.
Aktive Positionen von Donald Joseph
| Unternehmen | Position | Beginn |
|---|---|---|
| ACER THERAPEUTICS INC. | General Counsel | 01.04.2018 |
| Bio Ventures for Global Health | Direktor/Vorstandsmitglied | 06.04.2010 |
Ehemalige bekannte Positionen von Donald Joseph
| Unternehmen | Position | Ende |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 07.06.2023 |
| HUMANIGEN, INC. | General Counsel | 01.11.2015 |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | General Counsel | - |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | General Counsel | - |
Baker & McKenzie LLP (New York)
 Baker & McKenzie LLP (New York) Miscellaneous Commercial ServicesCommercial Services Baker & McKenzie LLP (New York) provides legal services. Its practice offers antitrust and competition, banking and finance, capital markets, compliance and investigations, dispute resolution, employment and compensation, environment and climate change, information technology and communications, intellectual property, international commercial and trade, mergers and acquisitions, private equity, real estate, restructuring and insolvency, and tax. The company was founded on July 6, 2004 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Ausbildung von Donald Joseph
| The University of Texas School of Law | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HUMANIGEN, INC. | Health Technology |
| ACHIEVE LIFE SCIENCES, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
| Bio Ventures for Global Health | |
| PATH Drug Solutions | Commercial Services |
Baker & McKenzie LLP (New York)
Baker & McKenzie LLP (New York) Miscellaneous Commercial ServicesCommercial Services Baker & McKenzie LLP (New York) provides legal services. Its practice offers antitrust and competition, banking and finance, capital markets, compliance and investigations, dispute resolution, employment and compensation, environment and climate change, information technology and communications, intellectual property, international commercial and trade, mergers and acquisitions, private equity, real estate, restructuring and insolvency, and tax. The company was founded on July 6, 2004 and is headquartered in New York, NY. | Commercial Services |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Abgenix, Inc. developed therapeutic products. It focused on the discovery, development and manufacturing of therapeutic antibodies. The firm's antibody development platform included manufacturing fully human antibody product candidates to a variety of disease targets. The company was founded by R. Scott Greer in 1996 and was headquartered in Fremont, CA. | Health Technology |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA. | Health Technology |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Health Technology |
